BMSCs also showed induced bortezomib-resistance NF-κB activity in MM cells, which was mediated by soluble factors, including IL-8 from BMSCs, which provides an explanation for bortezomib resistance in many MM patients [78]. This evidence concerns the gene CXCL8 and Miyoshi myopathy.